<DOC>
	<DOCNO>NCT02095301</DOCNO>
	<brief_summary>The objective study assess effect herbal extract mental energy healthy human subject .</brief_summary>
	<brief_title>Herbal Extract Study</brief_title>
	<detailed_description />
	<criteria>1 . Subject male female , 1870 year age , inclusive . 2 . Subject body mass index ( BMI ) ≥17.0 ≤32.9 kg/m2 visit 1 ( day 14 2 ) . 3 . Subject health condition would prevent him/her fulfil study requirement judge Investigator basis medical history , routine laboratory test result . 4 . Subject nonsmoker , define tobacco use ≥6 month prior visit 1 ( day 14 2 ) . 5 . Individual willing maintain habitual diet physical activity pattern throughout study period . 6 . Subject willing consume study product standardize meal . 7 . Individual willing abstain caffeinated beverage caffeinecontaining product 12 h prior test visit ( visit 2 , 3 , 4 ; day 0 , 3 , 6 ) . 8 . Subject willing abstain alcohol consumption avoid nonroutine vigorous physical activity 24 h prior test visit ( visit 2 , 3 , 4 ; day 0 , 3 , 6 ) . 9 . Subject willing discontinue vitamin/mineral dietary supplement use 2 week prior visit 2 ( day 0 ) throughout study period . 10 . Subject female willing schedule randomization visit ( visit 2 , day 0 ) luteal phase menstrual cycle , define day 15 end cycle , day 1 first day menses , appropriate . 11 . Subject understands study procedure sign form provide informed consent participate study authorization release relevant protect health information study Investigator . 1 . Subject unable understand and/or perform require test questionnaire ( i.e. , subject complete practice test , task ) . 2 . Subject color blind . 3 . Subject abnormal laboratory test result clinical significance , include , limited creatinine ≥1.5 mg/dL ALT AST ≥1.5X upper limit normal visit 1 ( day 14 2 ) . 4 . Subject know allergy sensitivity study product ingredient study product , standardize meals/snacks provide . 5 . Subject gastrointestinal condition could potentially interfere absorption study product ( e.g. , inflammatory bowel syndrome , celiac disease , history gastric bypass surgery ) . 6 . Subject diagnosed depression , schizophrenia , dementia last 2 year prior visit 1 ( day 14 2 ) . 7 . Subject history presence clinically important cardiac ( include , limited , atherosclerotic disease , history myocardial infarction , peripheral arterial disease , and/or stroke ) , renal , hepatic , endocrine ( include type 1 type 2 diabetes mellitus ) , pulmonary , biliary , pancreatic , neurologic disorder . 8 . Subject extreme dietary habit ( e.g. , vegan , Atkins diet , high protein ) . 9 . Subject uncontrolled hypertension ( systolic blood pressure ≥160 mm Hg diastolic blood pressure ≥100 mm Hg define blood pressure measure visit 1 , ( day 14 2 ) . One retest allow separate day prior visit 2 ( day 0 ) subject whose blood pressure exceed either cut point visit 1 . 10 . Subject history presence cancer prior 2 year , except nonmelanoma skin cancer . 11 . Subject signs/symptoms active infection clinical relevance ( e.g. , urinary tract respiratory infection ) . Test visit ( visit 2 , 3 , 4 ; day 0 , 3 , 6 ) reschedule allow subject symptomfree type systemic infection least 5 d. 12 . Subject recently use antibiotic ( within 5 test visit ; Appendix 1 ) . Test day ( visit 2 , 3 , 4 ; day 0 , 3 , 6 ) reschedule allow subject free antibiotic therapy least 5 d. 13 . Subject history use psychotropic medication within 6 month visit 2 ( day 0 ) throughout study period . 14 . Subject use prescription medication , include overthecounter medication within 2 week visit 2 ( day 0 ; Appendix 1 ) throughout study period . 15 . Subject use overthecounter prescription sleep aid product ( include dietary supplement ) within 2 week visit 2 ( day 0 ) throughout study period . 16 . Subject diagnosed sleep disorder ( e.g. , sleep apnea ) occupation sleep overnight hour irregular ( e.g. , 3rd shift overnight worker ) . 17 . Subject consumes excessive amount caffeine ( &gt; 4 cup caffeinated coffee/d &gt; 400 mg caffeine/d caffeinecontaining product ) . 18 . Subject female , pregnant , plan pregnant study period , lactating , childbearing potential unwilling commit use medically approve form contraception throughout study period . The method contraception must record source document . 19 . Subject recent history ( within 12 month screen ; visit 1 , day 14 2 ) strong potential alcohol substance abuse . Alcohol abuse define &gt; 14 drink per week ( 1 drink = 12 oz beer , 5 oz wine , 1½ oz distil spirit ) . 20 . Subject expose nonregistered drug product within 30 prior screening . 21 . Individual condition Investigator believe would interfere ability provide inform consent , comply study protocol , might confound interpretation study result put person undue risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>